# Contact TB-500 Get: Editorial Inquiries Only

> Contact TB-500 Get with editorial corrections and source suggestions for this thymosin beta-4 and TB-500 research digest. We do not sell, source, prescribe, or supply any compound.

Editorial corrections and source suggestions are welcome. Sales, sourcing, and clinical requests are not something we can answer.

## What we can help with

This is the contact page for TB-500 Get, an independent editorial digest of the thymosin beta-4 and TB-500 research literature. If you have found an error, have a peer-reviewed study you think belongs in the digest, or want to flag a citation that no longer resolves, the form below reaches the editorial desk.

We read every message about the accuracy of the content. Corrections to a dose, a date, a species, or a citation are exactly the kind of note that improves the site, and we are grateful for them.

## What we cannot help with

We cannot sell, source, price, supply, or help anyone obtain TB-500 or any other compound, and we cannot offer medical, clinical, or legal advice. We do not operate a pharmacy, a clinic, or a telehealth service, and we have no products to recommend or stock to check.

Questions about whether and how a compounded preparation might be lawfully obtained are clinical and regulatory matters for a licensed prescriber and pharmacist — the general framework is described, with FDA sources, on the legal-status page, but that is information about the landscape, not advice for an individual.

## Editorial inquiry form

Use the fields below to send an editorial note. No personal health information is needed, and none should be sent — this is an editorial inbox, not a clinical one.

---

A soft-paneled research desk on the TB-500 and thymosin beta-4 literature — each finding set in its own panel, the fragment-versus-full-length caveat and the FDA 503A status pressed in before anything else, and no clinic, vendor, or prescription behind the surface.